NovoSeven 1 mg
NovoSeven 1 mg is a medicine authorised by Swissmedic under authorisation number 58693. The authorisation holder is Novo Nordisk Pharma AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 27 March 2009 and the authorisation is valid without a time limit. ATC code B02BD08 places the medicine in the group Antihemorrhagics.
| Authorisation number | 58693 |
|---|---|
| Name | NovoSeven 1 mg |
| Full name | NovoSeven 1 mg, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
| Authorisation holder | Novo Nordisk Pharma AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | B02BD08 |
| First authorisation | 27 March 2009 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | NovoSeven 1 mg, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | B | 27 March 2009 |
| 2 | NovoSeven 2 mg, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | B | 27 March 2009 |
| 3 | NovoSeven 5 mg, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | B | 27 March 2009 |
| 4 | NovoSeven 8 mg, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | B | 12 March 2012 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 5 | 1 Flasche mit Pulver und 1 Spritze mit Lösungsmittel und Zubehör | B02BD08 | 06.01.1. | B | |
| 6 | 1 Flasche mit Pulver und 1 Spritze mit Lösungsmittel und Zubehör | B02BD08 | 06.01.1. | B | |
| 7 | 1 Flasche mit Pulver und 1 Spritze mit Lösungsmittel und Zubehör | B02BD08 | 06.01.1. | B | |
| 8 | 1 Flasche mit Pulver und 1 Spritze mit Lösungsmittel und Zubehör | B02BD08 | 06.01.1. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is NovoSeven 1 mg authorised in Switzerland?
Yes. NovoSeven 1 mg is authorised by Swissmedic under authorisation number 58693, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does NovoSeven 1 mg have?
NovoSeven 1 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of NovoSeven 1 mg?
The authorisation holder is Novo Nordisk Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.